WallStreetZenWallStreetZen

NASDAQ: VIRI
Virios Therapeutics Inc Stock Ownership - Who owns Virios Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Virios Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
William PridgenDirector2023-08-2115,335$1.30
$20.00kBuy
Gregory Scott DuncanCHIEF EXECUTIVE OFFICER2023-08-1725,000$1.25
$31.25kBuy

1 of 1

VIRI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIRI insiders and whales buy or sell their stock.

VIRI Shareholders

What type of owners hold Virios Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
William Pridgen4.16%801,489$375.90kInsider
Vanguard Group Inc1.08%208,883$97.97kInstitution
Renaissance Technologies LLC1.07%206,697$96.94kInstitution
Geode Capital Management LLC0.91%174,469$81.83kInstitution
Richard Alan Burch0.77%147,681$69.26kInsider
Gregory Scott Duncan0.30%57,461$26.95kInsider
State Street Corp0.27%52,828$24.78kInstitution
Mccollum Christoferson Group LLC0.19%37,000$17.35kInstitution
Raymond James Associates0.16%30,000$14.07kInstitution
Northern Trust Corp0.12%24,035$11.27kInstitution

1 of 3

VIRI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIRI4.47%5.34%Net Buying
CMMB0.99%5.96%
MTEM1.90%98.10%Net BuyingNet Buying
NTBL2.63%97.37%Net Selling
CHRO0.00%47.70%Net BuyingNet Buying
View Top Biotech Stocks

Virios Therapeutics Stock Ownership FAQ

Who owns Virios Therapeutics?

Virios Therapeutics (NASDAQ: VIRI) is owned by 4.47% institutional shareholders, 5.34% Virios Therapeutics insiders, and 90.19% retail investors. William Pridgen is the largest individual Virios Therapeutics shareholder, owning 801,489.00 shares representing 4.16% of the company. William Pridgen's Virios Therapeutics shares are currently valued at $375.90k.

If you're new to stock investing, here's how to buy Virios Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.